XML 16 R17.htm IDEA: XBRL DOCUMENT v2.4.0.8
Pension, Postretirement Health Care and Other Benefits
 9 Months Ended
Nov. 02, 2013
Compensation and Retirement Disclosure [Abstract]  
Pension, Postretirement Health Care and Other Benefits
Pension, Postretirement Health Care and Other Benefits
 
Pension and Postretirement Health Care Benefits
 
We have qualified defined benefit pension plans, unfunded nonqualified pension plans and provide certain postretirement health care benefits to eligible team members.
Net Pension and Postretirement
Health Care Benefits Expense
Pension Benefits
 
Postretirement Health Care Benefits
 
Three Months Ended
 
Nine Months Ended
 
Three Months Ended
 
Nine Months Ended
(millions)
Nov 2,
2013

 
Oct 27,
2012

 
Nov 2,
2013

 
Oct 27,
2012

 
Nov 2,
2013

 
Oct 27,
2012

 
Nov 2,
2013

 
Oct 27,
2012

Service cost
$
29

 
$
30

 
$
88

 
$
90

 
$
2

 
$
3

 
$
5

 
$
7

Interest cost
35

 
35

 
104

 
105

 
—

 
1

 
1

 
2

Expected return on assets
(59
)
 
(55
)
 
(176
)
 
(165
)
 
—

 
—

 
—

 
—

Amortization of losses
26

 
26

 
76

 
78

 
1

 
—

 
4

 
2

Amortization of prior service cost
(3
)
 
—

 
(8
)
 
—

 
(4
)
 
(3
)
 
(12
)
 
(7
)
Total
$
28

 
$
36

 
$
84

 
$
108

 
$
(1
)
 
$
1

 
$
(2
)
 
$
4


 
Other Benefits
 
We offer unfunded nonqualified deferred compensation plans to certain team members. We mitigate some of our risk of these plans through investing in vehicles, including company-owned life insurance and prepaid forward contracts in our own common stock, that offset a substantial portion of our economic exposure to the returns of these plans. These investment vehicles are general corporate assets and are marked to market with the related gains and losses recognized in the Consolidated Statements of Operations in the period they occur.
 
The total change in fair value for contracts indexed to our own common stock recognized in earnings was a pretax loss of $7 million and pretax income of $3 million for the three months ended November 2, 2013 and October 27, 2012, respectively, and pretax income of $5 million and $18 million for the nine months ended November 2, 2013 and October 27, 2012, respectively. For the nine months ended November 2, 2013 and October 27, 2012, we invested $11 million and $19 million, respectively, in such investment instruments. This activity is included in the Consolidated Statements of Cash Flows within other investing activities. Adjusting our position in these investment vehicles may involve repurchasing shares of Target common stock when settling the forward contracts as described in Note 6. The settlement dates of these instruments are regularly renegotiated with the counterparty.
 
Prepaid Forward Contracts on Target Common Stock
Number of
Shares

 
Contractual
Price Paid
per Share

 
Fair Value

 
Total Cash
Investment

(millions, except per share data)
 
 
 
October 27, 2012
1.2

 
$
45.46

 
$
76

 
$
54

February 2, 2013
1.2

 
45.46

 
73

 
54

November 2, 2013
1.1

 
46.52

 
72

 
52